Clinical Trial Update: Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated adding hydralazine and valproate to cisplatin-based chemoradiation for cervical cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Hydralazine (hydralazine)
• Valproate (valproate)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED